
This episode discusses Elon Musk's reported drug use, particularly ketamine, and its implications for his leadership at Tesla and SpaceX. The conversation features insights from Dr. Jeffrey Swisser about ketamine's effects and potential risks.
The episode opens with a Wall Street Journal article highlighting concerns from Tesla and SpaceX board members regarding Musk's ongoing drug use. The hosts mention Musk's previous drug-related incidents, including his infamous appearance on Joe Rogan's podcast.
Dr. Jeffrey Swisser joins the discussion to explain ketamine's medical uses and its psychological effects. He emphasizes that while ketamine can be beneficial in controlled environments, its recreational use poses risks of dependence and impaired functioning.
The hosts reflect on the broader implications of Musk's behavior, particularly regarding his influence and the lack of accountability from his board. They discuss the importance of having supportive relationships to help manage personal struggles.
The episode concludes with a cautionary note about the potential dangers of substance abuse, particularly for high-profile individuals like Musk, who may not face the same consequences as others.
Elon Musk's reported ketamine use raises concerns about his leadership at Tesla and SpaceX, discussed by Dr. Jeffrey Swisser and the hosts.

This episode stands out for the following: